Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

Malaria continues being a high-impact disease regarding public health worldwide; the WHO report for malaria in 2018 estimated that ~219 million cases occurred in 2017, mostly caused by the parasite Plasmodium falciparum. The disease cost the lives of more than 400,000 people, mainly in Africa. In sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambraño, Jennifer, Curtidor, Hernando, Avendaño, Catalina, Díaz-Arévalo, Diana, Roa, Leonardo, Vanegas, Magnolia, Patarroyo, Manuel E., Patarroyo, Manuel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012257/
https://www.ncbi.nlm.nih.gov/pubmed/32083140
http://dx.doi.org/10.1155/2019/3832513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012257/
https://www.ncbi.nlm.nih.gov/pubmed/32083140
http://dx.doi.org/10.1155/2019/3832513

Ejemplares similares